Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Parallel Group, Placebo Controlled, Multi-center Study of Fixed Dose Combinations of Solifenacin Succinate (6 mg and 9 mg) With Tamsulosin Hydrochloride OCAS 0.4 mg and Tamsulosin Hydrochloride OCAS 0.4 mg Monotherapy, in Male Subjects With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) With a Substantial Storage Component
Brief Summary: Clinical study to examine the efficacy, safety and tolerability of combination therapy of tamsulosin hydrochloride and solifenacin succinate compared to monotherapy of tamsulosin hydrochloride in the treatment of males with LUTS associated with BPH with a substantial storage component.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to solifenacin, Drug: Placebo to tamsulosin | Arm Label: 6 mg Solifenacin + 0.4 mg Tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: solifenacin succinate, Drug: tamsulosin hydrochloride | Arm Label: 9 mg Solifenacin + 0.4 mg Tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: solifenacin succinate, Drug: tamsulosin hydrochloride | Intervention Type: DRUG; Name: solifenacin succinate; Assigned to Arm(s): 6 mg Solifenacin + 0.4 mg Tamsulosin, 9 mg Solifenacin + 0.4 mg Tamsulosin | Intervention Type: DRUG; Name: tamsulosin hydrochloride; Assigned to Arm(s): 6 mg Solifenacin + 0.4 mg Tamsulosin, 9 mg Solifenacin + 0.4 mg Tamsulosin | Intervention Type: DRUG; Name: Placebo to solifenacin; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo to tamsulosin; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Tolterodine ER 4 mg QD; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Tamsulosin 0.4 mg QD; Assigned to Arm(s): N/A
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg | Arm Label: TOCAS 0.4 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride OCAS 0.4 mg | Arm Label: FDC 0.4 mg/6 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) | Arm Label: FDC 0.4 mg/9 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg) | Intervention Type: DRUG; Name: Placebo tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, FDC 0.4 mg/9 mg, Placebo | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg; Assigned to Arm(s): FDC 0.4 mg/9 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg); Assigned to Arm(s): FDC 0.4 mg/6 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg); Assigned to Arm(s): FDC 0.4 mg/9 mg
D: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: C; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: D; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: E; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride | Arm Label: F; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Arm Label: G; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Arm Label: H; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Intervention Type: DRUG; Name: tamsulosin hydrochloride; Assigned to Arm(s): E, F, G, H | Intervention Type: DRUG; Name: solifenacin succinate; Assigned to Arm(s): B, C, D, F, G, H | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A

Answer: C